Molnupiravir to be given free to symptomatic, categories 3 and above patients - Khairy
The antiviral drug Molnupiravir will be given free of charge to COVID-19 patients who are symptomatic for at least five days or category three, four and five patients, Health Minister Khairy Jamaluddin said. - REUTERSpic
KUALA LUMPUR: The antiviral drug Molnupiravir will be given free of charge to COVID-19 patients who are symptomatic for at least five days or category three, four and five patients, Health Minister Khairy Jamaluddin said.
He said although the adult population full vaccination rate was now close to 90 per cent, the Health Ministry (MOH) finds that COVID-19 infections were still occurring.
"We need these treatment pills in addition to our vaccination program. We found that with these pills we give doctors the option to give them to those who have not been vaccinated and those who have. It will be given for free.
The government, through the Health Ministry, signed a Letter of Undertaking (LoU) to procure the antiviral drug Molnupiravir to add new innovative treatment options in the fight against COVID-19.
Molnupiravir is also proven to be effective against more aggressive COVID-19 variants such as Gamma, Delta and Mu.
-- BERNAMA
Must-Watch Video
Stay updated with our news